NCT03235232 - BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension | Biotech Hunter

Enrollment

406

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

October 31, 2023

Conditions

Ocular HypertensionPrimary Open-angle Glaucoma

Interventions

DRUG

BREMEN eye drops

1 drop in the affected eye(s), twice a day (approximately each 12 hours) for 8 weeks.

DRUG

Combigan®

1 drop of Combigan® in the affected eye(s), twice a day (approximately each 12 hours) for 8 weeks.

Trial Locations (1)

Allegisa, Campinas